Oxygenta Pharmaceutical logo

Oxygenta Pharmaceutical shareholders and shareholding pattern

BSE: 524636Pharmaceuticals & BiotechnologySmall Cap

Last close ₹46.07down ₹0.93 (1.98%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹47.00.

52-week range of traded prices to 23 Oct 2026
₹43.00Low, 11 Jun 2026₹71.59High, 12 Aug 2026
Market cap
₹170 Cr2,423rd largest listed
P/E
Lossover the last 12 months
P/B
Net worth zero or below
Dividend yield
Nonein the last 12 months
ROE
Net worth zero or below
ROCE
−15.1%
Debt to equity
Net worth zero or below
Volume, BSE
6,726

Who owns Oxygenta Pharmaceutical, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters56.54%
  • Indian institutions0.03%
  • Individuals and others43.44%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Indian institutions
  • Individuals and others
Per centDec 2016Filed 19 JanMar 2017Filed 20 AprJun 2017Filed 21 JulSep 2017Filed 17 OctDec 2017Filed 19 JanMar 2018Filed 30 MayJun 2018Filed 27 JulSep 2018Filed 25 OctDec 2018Filed 21 JanMar 2019Filed 30 SepJun 2019Filed 30 SepSep 2019Filed 18 OctDec 2019Filed 22 JanMar 2020Filed 11 MayJun 2020Filed 15 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 19 AprJun 2021Filed 20 JulSep 2021Filed 8 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 21 JanMar 2023Filed 20 AprJun 2023Filed 2 AugSep 2023Filed 18 OctDec 2023Filed 20 JanMar 2024Filed 20 AprJun 2024Filed 20 JulSep 2024Filed 21 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 25 SepSep 2025Filed 21 OctDec 2025Filed 12 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 16 Oct
36.78%36.78%36.78%36.78%36.78%36.78%36.78%36.78%36.78%17.17%17.17%17.17%17.17%17.17%17.17%17.17%17.17%17.17%17.17%12.33%12.33%12.33%12.33%12.33%12.33%8.99%26.80%29.73%29.73%29.73%33.69%53.28%51.12%51.12%57.95%57.95%55.93%56.54%56.54%56.54%
Indian promoters35.31%35.31%35.31%35.31%35.31%35.31%35.31%35.31%35.31%15.70%15.70%15.70%15.70%15.70%15.70%15.70%15.70%15.70%15.70%11.28%11.28%11.28%11.28%11.28%11.28%8.99%26.80%29.73%29.73%29.73%33.69%53.28%51.12%51.12%57.95%57.95%55.93%56.54%56.54%56.54%
Foreign promoters1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.47%1.06%1.06%1.06%1.06%1.06%1.06%–––––––––––––––
63.22%63.22%63.22%63.22%63.22%63.22%63.22%63.22%63.22%82.83%82.83%82.83%82.83%82.83%82.83%82.83%82.83%82.83%82.83%87.67%87.67%87.67%87.67%87.67%87.67%91.01%73.20%70.27%70.27%70.27%66.31%46.72%48.88%48.88%42.05%42.05%44.07%43.46%43.46%43.46%
Shares in issue1,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,02,01,3001,42,01,3001,42,01,3001,42,01,3001,42,01,3001,42,01,3001,42,01,3001,42,01,3003,34,83,5003,34,83,5003,34,83,5003,34,83,5003,54,83,5003,54,83,5003,69,83,5003,69,83,5003,69,83,5003,69,83,5003,69,83,5003,69,83,5003,69,83,5003,69,83,500
Shares locked in–––––––––––––––––––40,00,00040,00,00040,00,00040,00,00040,00,00040,05,49367,66,1012,02,18,9002,02,18,9002,02,18,90076,34,70096,34,70096,34,7001,11,34,70035,00,00035,00,00035,89,30620,00,000500––
Promoters' shares locked in–––––––––––––––––––––––––10,21,10086,31,70086,31,70086,31,70076,34,70096,34,70096,34,70096,34,70020,00,00020,00,00020,00,00020,00,000–––
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Number of Oxygenta Pharmaceutical shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersDec 2016Filed 19 JanMar 2017Filed 20 AprJun 2017Filed 21 JulSep 2017Filed 17 OctDec 2017Filed 19 JanMar 2018Filed 30 MayJun 2018Filed 27 JulSep 2018Filed 25 OctDec 2018Filed 21 JanMar 2019Filed 30 SepJun 2019Filed 30 SepSep 2019Filed 18 OctDec 2019Filed 22 JanMar 2020Filed 11 MayJun 2020Filed 15 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 19 AprJun 2021Filed 20 JulSep 2021Filed 8 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 21 JanMar 2023Filed 20 AprJun 2023Filed 2 AugSep 2023Filed 18 OctDec 2023Filed 20 JanMar 2024Filed 20 AprJun 2024Filed 20 JulSep 2024Filed 21 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 25 SepSep 2025Filed 21 OctDec 2025Filed 12 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 16 Oct
All shareholders8,8538,8528,8568,8478,8338,8148,7968,7968,7898,7718,7618,7608,7608,7588,7588,7598,7638,7628,7628,7558,8739,0389,0049,0009,1018,9958,9878,9729,05110,1029,97010,15410,10710,03010,09410,17910,21510,20510,19610,279
99999999999999999999999995999912111111662222
Indian promoters88888888888888888888888885999912111111662222
Foreign promoters1111111111111111111111111–––––––––––––––
8,8448,8438,8478,8388,8248,8058,7878,7878,7808,7628,7528,7518,7518,7498,7498,7508,7548,7538,7538,7468,8649,0298,9958,9919,0928,9908,9788,9639,04210,0939,95810,14310,09610,01910,08810,17310,21310,20310,19410,277
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Oxygenta Pharmaceutical promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is VIRUPAKSHA ORGANICS LIMITED, 56.50%.Promoter buying and selling

Holder
VIRUPAKSHA ORGANICS LIMITEDIndian companies, trusts and others56.50%2,08,96,975
CHANDRA MOULISWAR REDDY GANGAVARAMIndividuals and Hindu undivided families0.03%12,895
No promoter shares are reported as pledged.

Largest public holders of Oxygenta Pharmaceutical, filing by filing

Per cent, on the same shares as the split above.

HolderDec 2016Filed 19 JanMar 2017Filed 20 AprJun 2017Filed 21 JulSep 2017Filed 17 OctDec 2017Filed 19 JanMar 2018Filed 30 MayJun 2018Filed 27 JulSep 2018Filed 25 OctDec 2018Filed 21 JanMar 2019Filed 30 SepJun 2019Filed 30 SepSep 2019Filed 18 OctDec 2019Filed 22 JanMar 2020Filed 11 MayJun 2020Filed 15 JulSep 2020Filed 19 OctDec 2020Filed 19 JanMar 2021Filed 19 AprJun 2021Filed 20 JulSep 2021Filed 8 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 18 JulSep 2022Filed 21 OctDec 2022Filed 21 JanMar 2023Filed 20 AprJun 2023Filed 2 AugSep 2023Filed 18 OctDec 2023Filed 20 JanMar 2024Filed 20 AprJun 2024Filed 20 JulSep 2024Filed 21 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 25 SepSep 2025Filed 21 OctDec 2025Filed 12 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 16 Oct
SRAVANI REDDY GANTLAResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––13.40%13.40%13.40%13.40%12.65%12.65%12.13%12.13%6.78%6.78%6.78%6.78%6.78%6.78%
SUBBA REDDY BHIMAVARAPUNon-resident Indians––––––––––––––––––––––––10.79%––4.58%4.58%4.58%4.32%4.32%4.14%4.14%––4.14%4.14%4.14%4.14%
SUNIL V. CHAWDAINResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––––––––––––––2.97%
KUMUDA KATASANIResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––––––2.51%2.40%2.40%2.27%2.27%2.27%2.27%2.27%2.27%
AAKANKSHA M CHAWDAResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––––1.54%1.54%1.54%1.54%1.54%1.54%
MANOJ S. CHAWDAResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––––1.54%1.54%1.54%1.54%1.54%1.54%
SNIGDHA VANKINENIResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––––––1.47%1.47%1.47%1.47%
DEVARAPALLY VENKATESWARA REDDYResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––2.70%2.70%2.70%2.68%2.12%1.31%1.31%1.31%
SATYANARAYANA REDDY BANDIResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––1.35%1.35%1.35%1.33%1.30%1.29%1.29%1.29%
B SUBBA REDDYResident individuals, over ₹2 lakh at face value19.63%19.63%18.95%19.63%19.63%13.45%19.63%13.45%19.63%19.63%19.63%4.58%4.58%4.58%4.58%4.58%4.58%4.58%4.58%3.29%3.29%3.29%3.29%3.29%3.29%3.29%1.40%1.40%1.40%1.40%1.32%1.32%1.26%1.26%1.26%1.26%1.26%1.26%1.26%1.26%
SUNIL V. CHAWDAResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––––––––––2.97%2.97%2.97%2.97%2.97%–
JAWAHAR K REDDYNon-resident Indians–––––––––––––––––––––––––––––––––––4.30%––––
SANAGARI KONDAL REDDYResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––1.49%1.49%1.49%1.41%1.41%1.35%1.35%1.35%1.11%––––
SANDEEP KUMAR REDDY KOMMIDIResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––8.23%8.23%8.23%7.77%7.77%7.45%7.45%––––––
QEMIQ PHARMA PRIVATE LIMITEDCompanies––––––––––––––––––––24.65%–––––––11.80%11.80%11.14%–––––––––
PUSHPALATHA VUSTALAResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––8.96%8.96%8.96%8.45%–––––––––
HEMANTH KUMAR KOWDIResident individuals, over ₹2 lakh at face value–––––––––––––––––––––3.52%3.52%3.52%3.52%3.52%1.49%1.49%1.49%1.49%1.41%–––––––––
KISHORE BABU BATHULAResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––3.52%1.49%1.49%1.49%1.49%1.41%–––––––––
SRIVANI JUNOOTHULAResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––2.68%1.13%1.13%1.13%1.13%1.07%–––––––––
ARR CAPITAL INVESTMENT PRIVATE LIMITEDCompanies–––––––––––––––––––24.65%–24.65%24.65%24.65%24.65%24.65%10.45%11.35%––––––––––––
Vustala PushpalathaResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––8.96%–––––––––––––
K. Sandeep Kumar ReddyResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––8.23%–––––––––––––
SUDHARANI POPURIResident individuals, over ₹2 lakh at face value–––––––––9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%7.04%7.04%7.04%7.04%7.04%7.04%3.52%1.49%–––––––––––––
S Kondal ReddyResident individuals, over ₹2 lakh at face value––––––––––––––––––––––––––1.49%–––––––––––––
POPURI ANKINEEDUResident individuals, over ₹2 lakh at face value–––––––––9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%9.80%7.04%7.04%7.04%7.04%7.04%7.04%3.38%1.43%–––––––––––––
VISWANADH KANDULAResident individuals, over ₹2 lakh at face value––––––––––––––––1.96%1.96%1.96%1.41%1.41%1.41%1.41%1.41%1.41%1.41%––––––––––––––
DEVABHAKTUNI VIDYASAGARResident individuals, over ₹2 lakh at face value–––––––––1.65%1.65%1.65%1.65%1.65%1.65%–1.65%1.65%1.65%––––––1.18%––––––––––––––
V N SUNANDA REDDYResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––1.07%––––––––––––––
DURGA MAHIDHAR UPPALAPATIResident individuals, over ₹2 lakh at face value–––––––––––––––––––1.06%1.06%1.06%1.06%1.06%1.06%1.06%––––––––––––––
GOWTHAM REDDY VNon-resident Indians–––––––––––––––––––––––––1.06%––––––––––––––
SINDHURI VONGUMALLIResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––1.06%––––––––––––––
VIDYA SAGAR DEVABHAKTUNIResident individuals, over ₹2 lakh at face value––––––––––––––––––––1.18%1.18%1.18%1.18%1.18%–––––––––––––––
KOWDI HEMANTH KUMARResident individuals, over ₹2 lakh at face value–––––––––––––––––––3.52%3.52%–––––––––––––––––––
UPPALAPATI DURGA MAHIDHARResident individuals, over ₹2 lakh at face value1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%1.48%–––––––––––––––––––––
CH AVINASH REDDYResident individuals, over ₹2 lakh at face value1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%1.23%–––––––––––––––––––––
KANDULA VISWANADHResident individuals, over ₹2 lakh at face value–––––––––1.96%1.96%1.96%1.96%1.96%1.96%1.96%––––––––––––––––––––––––
DEVABHAKTUNI VIYASAGARResident individuals, over ₹2 lakh at face value–––––––––––––––1.65%––––––––––––––––––––––––
Vidya Sagar DOther non-institutions––1.65%–––––1.65%–––––––––––––––––––––––––––––––
D Vidya SagarOther non-institutions1.65%––1.65%1.65%–1.65%–––––––––––––––––––––––––––––––––
Coral Drugs LimitedOther non-institutions1.96%1.96%1.96%1.96%1.96%–––––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent. The 40 holders most recently named are shown, of 41 holders the filings name.